181 related articles for article (PubMed ID: 19494278)
21. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer.
Monteleone NJ; Moore AE; Iacona JR; Lutz CS; Dixon DA
Sci Rep; 2019 Apr; 9(1):5405. PubMed ID: 30931980
[TBL] [Abstract][Full Text] [Related]
22. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.
Hughes D; Otani T; Yang P; Newman RA; Yantiss RK; Altorki NK; Port JL; Yan M; Markowitz SD; Mazumdar M; Tai HH; Subbaramaiah K; Dannenberg AJ
Cancer Prev Res (Phila); 2008 Sep; 1(4):241-9. PubMed ID: 19138967
[TBL] [Abstract][Full Text] [Related]
23. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.
Ding Y; Tong M; Liu S; Moscow JA; Tai HH
Carcinogenesis; 2005 Jan; 26(1):65-72. PubMed ID: 15358636
[TBL] [Abstract][Full Text] [Related]
24. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells.
Tong M; Ding Y; Tai HH
Carcinogenesis; 2006 Nov; 27(11):2170-9. PubMed ID: 16632868
[TBL] [Abstract][Full Text] [Related]
25. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
[TBL] [Abstract][Full Text] [Related]
26. 15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human gastric cancer.
Liu Z; Wang X; Lu Y; Du R; Luo G; Wang J; Zhai H; Zhang F; Wen Q; Wu K; Fan D
Cancer Biol Ther; 2010 Oct; 10(8):780-7. PubMed ID: 20699658
[TBL] [Abstract][Full Text] [Related]
27. UV radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression.
Judson BL; Miyaki A; Kekatpure VD; Du B; Gilleaudeau P; Sullivan-Whalen M; Mohebati A; Nair S; Boyle JO; Granstein RD; Subbaramaiah K; Krueger JG; Dannenberg AJ
Cancer Prev Res (Phila); 2010 Sep; 3(9):1104-11. PubMed ID: 20643784
[TBL] [Abstract][Full Text] [Related]
28. 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors.
Yan M; Myung SJ; Fink SP; Lawrence E; Lutterbaugh J; Yang P; Zhou X; Liu D; Rerko RM; Willis J; Dawson D; Tai HH; Barnholtz-Sloan JS; Newman RA; Bertagnolli MM; Markowitz SD
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9409-13. PubMed ID: 19470469
[TBL] [Abstract][Full Text] [Related]
29. Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer.
Backlund MG; Mann JR; Holla VR; Shi Q; Daikoku T; Dey SK; DuBois RN
Cancer Res; 2008 Nov; 68(22):9331-7. PubMed ID: 19010907
[TBL] [Abstract][Full Text] [Related]
30. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer.
Tai HH; Tong M; Ding Y
Prostaglandins Other Lipid Mediat; 2007 May; 83(3):203-8. PubMed ID: 17481556
[TBL] [Abstract][Full Text] [Related]
31. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
Tai HH; Chi X; Tong M
Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448
[TBL] [Abstract][Full Text] [Related]
32. COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells.
Prima V; Kaliberova LN; Kaliberov S; Curiel DT; Kusmartsev S
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1117-1122. PubMed ID: 28096371
[TBL] [Abstract][Full Text] [Related]
33. Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene.
Li M; Xie J; Cheng L; Chang B; Wang Y; Lan X; Zhang D; Yin Y; Cheng N
Cancer Invest; 2008 Nov; 26(9):905-12. PubMed ID: 19034772
[TBL] [Abstract][Full Text] [Related]
34. Colon tumour cells increase PGE(2) by regulating COX-2 and 15-PGDH to promote survival during the microenvironmental stress of glucose deprivation.
Roberts HR; Smartt HJ; Greenhough A; Moore AE; Williams AC; Paraskeva C
Carcinogenesis; 2011 Nov; 32(11):1741-7. PubMed ID: 21926111
[TBL] [Abstract][Full Text] [Related]
35. Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase.
Hazra S; Batra RK; Tai HH; Sharma S; Cui X; Dubinett SM
Mol Pharmacol; 2007 Jun; 71(6):1715-20. PubMed ID: 17412838
[TBL] [Abstract][Full Text] [Related]
36. Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions.
Pande K; Ueda R; Machemer T; Sathe M; Tsai V; Brin E; Delano MJ; Van Rooijen N; McClanahan TK; Talmadge JE; Moldawer LL; Phillips JH; LaFace DM
Mol Ther; 2009 Mar; 17(3):508-15. PubMed ID: 19127252
[TBL] [Abstract][Full Text] [Related]
37. 15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.
Lu D; Han C; Wu T
Oncogene; 2014 Feb; 33(9):1101-12. PubMed ID: 23542179
[TBL] [Abstract][Full Text] [Related]
38. Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma.
Tatsuwaki H; Tanigawa T; Watanabe T; Machida H; Okazaki H; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Muguruma K; Sawada T; Hirakawa K; Higuchi K; Arakawa T
Cancer Sci; 2010 Feb; 101(2):550-8. PubMed ID: 19917058
[TBL] [Abstract][Full Text] [Related]
39. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.
Yan M; Rerko RM; Platzer P; Dawson D; Willis J; Tong M; Lawrence E; Lutterbaugh J; Lu S; Willson JK; Luo G; Hensold J; Tai HH; Wilson K; Markowitz SD
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17468-73. PubMed ID: 15574495
[TBL] [Abstract][Full Text] [Related]
40. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
